Compass therapeutics to participate in upcoming investor events

Boston, june 01, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the following investor events during the month of june 2023.
CMPX Ratings Summary
CMPX Quant Ranking